Since the COVID-19 outbreak, Chinese central SOEs have been making all-out efforts to support the battle against the virus not only in medical material production and development but also by transporting supplies to the front-lines, and in other ways as well.
China National Pharmaceutical Group Co., Ltd. (Sinopharm) has used its technology and capacity advantages to develop and produce nucleic acid diagnostic reagents soon after the outbreak of novel coronavirus.
Chinese central state-owned enterprises (SOEs) have been in full swing in guaranteeing anti-epidemic and everyday necessities in response to the resurgence of the COVID-19 epidemic.
Central state-owned enterprises (SOEs) have been playing a key role in guaranteeing communication services, and raising people's anti-epidemic awareness as well as supporting nucleic acid test during the recent COVID-19 resurgence with the use of advanced technologies.
Central SOEs in civil aviation and tourism sectors allocated their operation plans and service projects to provide easy travel services after the resurgence of the COVID-19 epidemic in Nanjing, East China's Jiangsu Province.
China Unicom lost no time in guaranteeing an effective emergency communication system at Shanghai Pudong International Airport in the wee hours of Aug 3 as a mass nucleic acid test for nearly 50,000 people had been carried out at the airport since the evening of Aug 2.
Sinopec Yizheng Chemical Fibre Co., Ltd., a subsidiary of China Petrochemical Corporation (Sinopec Group), successfully developed a colored meltblown cloth with high efficiency and low-resistance for mask production on March 16.
China Railway 25th Bureau Group Co., Ltd., a subsidiary of China Railway Construction Corporation Limited (CRCC), weathered the storm of the COVID-19 pandemic together with the local people of Sri Lanka.
China Aerospace Science and Industry Corporation Limited (CASIC) recently developed a positive pressure protection suit based on electric airing technology that is expected to support prevention and control of COVID-19 during the post-pandemic period.
China National Chemical Engineering Group Corporation Ltd (CNCEC) signed an agreement with Xiangyang in Central China's Hubei province on supporting its post-epidemic revitalization and high-quality development on Nov 25.
China Certification & Inspection Group (CCIC) has been in full swing in thoroughly disinfecting imported cold-chain foods since early November.
The 12th melt-blown fabric production line in Sinopec Yizheng Chemical Fibre Co., Ltd of China Petrochemical Corporation (Sinopec Group) went into service on May 9, the last of Sinopec Group's 16 melt-blown production lines to go into operation.
China Huadian Corporation Ltd. (CHD) has advanced some of its engineering projects domestically and abroad while maintaining good prevention and control of COVID-19.
Chinese enterprises inEgyptare making efforts to maintain the country's economic growth and stabilize its employment situation at a time when the global economy is being seriously hit by COVID-19 around the world.
The Chinese government and Chinese enterprises in Ethiopia have been devoted to fighting against COVID-19 in the country since the pandemic burst out.
Hubei Huaqiang High-Tech Co., Ltd., a subsidiary of China South Industries Group Co., Ltd. (CSGC), made a breakthrough in mask production amid the COVID-19 outbreak.
A large-scale all-cargo carrier of China Eastern Air Holding Co. Ltd (China Eastern) landed at Shanghai Pudong International Airport on Jan 31, carrying 249,600 protection suits and 136,000 masks from Amsterdam, the Netherlands.
A recombinant vaccine against the COVID-19 jointly developed by two subsidiaries of State Development & Investment Corp., Ltd. (SDIC) and the Academy of Military Medical Sciences was approved to start clinical testing on March 16.
China Southern Air Holding Company (China Southern), a main airline in China, provided 100,000 masks to Korean Air to support COVID-19 epidemic prevention and control on March 16.